Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

Novartis Launches Two Joint Working Projects With NHS Cancer Vanguard Sites, Using Data Analysis...


Novartis announced the launch of two new Joint Working Projects with National Cancer Vanguard sites,...

Micell Technologies Announces Expanded Patent Estate


Micell® Technologies, Inc., a privately-held, development-stage biomedical company, today provided an update on its recently...

Invictus Opens TSX Venture Exchange Trading as GENE for the First Time


INVICTUS MD STRATEGIES CORP. is pleased to announce that , Gene Simmons, Chief Evangelist Officer...

Envigo expands Livermore (USA) surgical facilities to meet rising demand from West Coast companies


Envigo is investing in an expansion of its surgical facility at its Livermore, California site...

Agendia Announces CE Mark for NGS-Based MammaPrint® BluePrint® Kit Enhancing Access to Personalized Treatment...


Agendia, Inc., a world leader in personalized medicine and molecular cancer diagnostics, announces that its...

Introducing SMi’s6thannual conference on Pharmaceutical Freeze Drying Technologythis June 2018


SMi Group are delighted to announce the 6thannual Pharmaceutical Freeze Drying Technology conference, being held...

Introducing SMi’s5th conference on Drug Safety 2018 this June


Drug Safety 2018 aims to discuss the latest findings and current thinking on pharmacovigilance. Importantly,...

Discover Novel Based Vial Based Technology, Presented by Roche this May


Building on the success of SMi's 10th Annual Flagship Conference Pre-Filled Syringes, SMi are thrilled...

Sarepta Therapeutics gazes FDA approval of Golodirsen (SRP-4053) in Patients with Duchenne Muscular Dystrophy...


Sarepta Therapeutics, Inc , a commercial-stage biopharmaceutical company focused on the discovery and development of...

Largest Real-World Data Analysis Reveals Findings Of Non-Valvular Atrial Fibrillation Patients Receiving Direct Oral...


Bristol-Myers Squibb Company and Pfizer Inc. will present findings from a real-world data (RWD) analysis...